Niki BioSolutions, Inc. (NIKI) Short term Debt (2017 - 2022)
Niki BioSolutions' (NIKI) quarterly Short term Debt came in at $3.0 million in Q4 2022, up 26241.21% YoY from N/an in Q4 2021, and little changed on a QoQ basis from $3.0 million in Q2 2022.
Niki BioSolutions, Inc. (NIKI) Short term Debt (2017 - 2022) Analysis & Trends
Niki BioSolutions (NIKI) has 6 years of Short term Debt data on file, last reported at $3.0 million in Q4 2022.
- Quarterly Short term Debt rose 26241.21% year-over-year to $3.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $3.0 million (up 26241.21% YoY) and the FY2025 annual result came in at $3.4 million, up 5.56% from the prior year.
- Short term Debt steadied at $3.0 million in Q4 2022, from $3.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $47.5 billion in Q2 2020 to a low of $11389.0 in Q4 2021.
- A 5-year average of $5.3 billion and a median of $145926.0 in 2020 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2019 — Short term Debt slumped 99.69% — and 2022, when it jumped 26241.21%.
- Tracing NIKI's Short term Debt over 5 years: stood at $13.5 million in 2018, then tumbled by 99.69% to $41593.0 in 2019, then soared by 250.84% to $145926.0 in 2020, then tumbled by 92.2% to $11389.0 in 2021, then jumped by 26241.21% to $3.0 million in 2022.
- The last three Short term Debt figures came in at $3.0 million (Q4 2022), $3.0 million (Q2 2022), and $11389.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Dec 31, 2021 | 11,389.00 |
| Jun 30, 2021 | 133,761.00 |
| Dec 31, 2020 | 145,926.00 |
| Jun 30, 2020 | 112,013.00 |
| Apr 30, 2020 | 47.48 Bn |
| Dec 31, 2019 | 41,593.00 |
| Dec 31, 2018 | 13.50 Mn |
| Dec 31, 2017 | 480,000.00 |